Literature DB >> 32474576

Dose Optimization of Hydroxychloroquine for Coronavirus Infection 2019: Do Blood Concentrations Matter?

Matthew M Ippolito1,2,3, Charles Flexner1,2.   

Abstract

Entities:  

Keywords:  COVID-19; editorial; hydroxychloroquine; pharmacokinetics

Mesh：

Substances：

Year:  2020        PMID： 32474576      PMCID： PMC7314247          DOI： 10.1093/cid/ciaa691

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  17 in total

1.  Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies.

Authors:  Jianjun Gao; Zhenxue Tian; Xu Yang
Journal:  Biosci Trends       Date:  2020-02-19       Impact factor: 2.400

2.  Dosage of antimalarial drugs for children with juvenile rheumatoid arthritis and systemic lupus erythematosus. A clinical study with determination of serum concentrations of chloroquine and hydroxychloroquine.

Authors:  A L Laaksonen; V Koskiahde; K Juva
Journal:  Scand J Rheumatol       Date:  1974       Impact factor: 3.641

3.  Treatment of hydroxychloroquine overdose.

Authors:  K Marquardt; T E Albertson
Journal:  Am J Emerg Med       Date:  2001-09       Impact factor: 2.469

Review 4.  Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications.

Authors:  S Krishna; N J White
Journal:  Clin Pharmacokinet       Date:  1996-04       Impact factor: 6.447

5.  Effect of Antiretroviral Therapy on Plasma Concentrations of Chloroquine and Desethyl-chloroquine.

Authors:  Matthew M Ippolito; Jeffrey M Jacobson; Michael M Lederman; Markus Winterberg; Joel Tarning; Theresa A Shapiro; Charles Flexner
Journal:  Clin Infect Dis       Date:  2018-10-30       Impact factor: 9.079

6.  Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Patients.

Authors:  Sophie Perinel; Manon Launay; Élisabeth Botelho-Nevers; Éric Diconne; Aurore Louf-Durier; Raphaël Lachand; Martin Murgier; Dominique Page; Régine Vermesch; Guillaume Thierry; Xavier Delavenne
Journal:  Clin Infect Dis       Date:  2020-11-19       Impact factor: 9.079

Review 7.  Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.

Authors:  K D Rainsford; Ann L Parke; Matthew Clifford-Rashotte; W F Kean
Journal:  Inflammopharmacology       Date:  2015-08-06       Impact factor: 5.093

8.  Optimizing Hydroxychloroquine Dosing for Patients With COVID-19: An Integrative Modeling Approach for Effective Drug Repurposing.

Authors:  Maria Garcia-Cremades; Belen P Solans; Emma Hughes; Jacqueline P Ernest; Erika Wallender; Francesca Aweeka; Anne F Luetkemeyer; Radojka M Savic
Journal:  Clin Pharmacol Ther       Date:  2020-05-12       Impact factor: 6.875

9.  No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection.

Authors:  J M Molina; C Delaugerre; J Le Goff; B Mela-Lima; D Ponscarme; L Goldwirt; N de Castro
Journal:  Med Mal Infect       Date:  2020-03-30       Impact factor: 2.152

10.  Hydroxychloroquine in Coronavirus Disease 2019 Patients: What Still Needs to Be Known About the Kinetics.

Authors:  Guillaume Martin-Blondel; Stéphanie Ruiz; Marlène Murris; Stanilas Faguer; Véronigue Duhalde; Frédéric Eyvrard; Jacques Izopet; Jean-Michel Mansuy; Yves Rolland; Karen Delavigne; Rosine Guimbaud; Grégory Pugnet; Jean-Marie Conil; Bernard Georges; Pierre Delobel; Vincent Minville; Stein Silva Sifontes; Didier Concordet; Peggy Gandia
Journal:  Clin Infect Dis       Date:  2020-12-31       Impact factor: 9.079
View more
  1 in total

1.  Hydroxychloroquine and mortality in COVID-19 patients: a systematic review and a meta-analysis of observational studies and randomized controlled trials.

Authors:  Augusto Di Castelnuovo; Simona Costanzo; Antonio Cassone; Roberto Cauda; Giovanni De Gaetano; Licia Iacoviello
Journal:  Pathog Glob Health       Date:  2021-06-15       Impact factor: 2.894
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.